Virogin Biotech reposted this
Exciting news from Virogin Biotech! We're thrilled to announce that our promising clinical trial data for VG161 in advanced HCC has been selected for a poster presentation at ASCO 2024. https://lnkd.in/gzJgCjvH Please visit us at Poster Board: 85, Session Time: 1:30 PM - 4:30 PM, June 1, 2024. Our latest results will showcase significant survival benefits for patients with advanced Hepatocellular Carcinoma with no treatment options. Details of the poster presentation: Title: Clinical outcomes from a phase I trial of the novel oncolytic virus VG161 in patients with hepatocellular carcinoma refractory after two prior lines of therapy including checkpoint inhibitors. Poster Session: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary Abstract Number: 4105 Poster Board: 85 Session Time: 1:30 PM - 4:30 PM, June 1, 2024 These advances underscore our commitment to pioneering cancer therapies that truly make a difference. #ASCO2024 #Cancer #Oncology #HCC #Hepatocellular Carcinoma #OncolyticVirus #ViroginBiotech
